Dow Development Laboratories’ core expertise is in the development, manufacture, and testing of topical (semi-solid and liquid) drug products for clinical use. Always with the patient in mind, and following QbD principles, products are designed to be disease-compatible, cosmetically elegant and stable. Our formulation, analytical, production, quality, and clinical labeling teams have decades of experience moving products quickly toward regulatory approval. Our clients range from start-ups to large multi-national companies, and all appreciate our unparalleled customer service and attention to their unique project needs. DDL works seamlessly with its parent company Symbio, a specialty CRO with over 20 years of success in conducting clinical trials, to rapidly advance drug product programs through all stages of clinical development.